Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 262 | Published : January 2022 | | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Brain Tumor Drugs Market Definition

The brain tumor drugs market consists of sales of brain tumor drugs and related services by entities (organizations, sole traders and partnerships) that produce brain tumor drugs to diagnose and cure a mass growth of abnormal cells in the human brain. These drugs are either used alone or in combinations, depending on the type, size and location of the tumor.  For example, Afinitor (Everolimus), BiCNU (Carmustine), Everolimus, Carmustine, Temozolomide and Avastin (Bevacizumab) are some of the drugs included in this market.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing. Brain tumor drugs manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Brain Tumor Drugs Market Size

The global brain tumor drugs market reached a value of nearly $5,656.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.5% since 2015. The brain tumor drugs market is expected to grow from $5,656.4 million in 2020 to $9,128.1 million in 2025 at a rate of 10%. The brain tumor drugs market is then expected to grow at a CAGR of 8.8% from 2025 and reach $13,932 million in 2030.  

Growth in the historic period in the brain tumor drugs market resulted increasing prevalence of neurological disorders, increased healthcare expenditure, increased number of approvals for oncology (cancer) drugs, increase in pharmaceutical R&D expenditure, and advances in cancer drug discovery. The brain tumor drugs market was restrained increasing use of targeted therapies, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.

Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs, and revised FDA regulations to facilitate biologics drug development. Factors that could hinder the growth of the brain tumor drugs market in the future include high costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, and coronavirus pandemic.

Brain Tumor Drugs Market Drivers

The key drivers of the brain tumor drugs market include:

Increase In Brain Tumor Incidence Rate

The rise in the number of brain tumor cases across the globe is likely to contribute to the growth of the brain tumor drugs market during the forecast period. Brain tumors account for 85% to 90% of all primary central nervous system (CNS) tumors. According to the American Cancer Society, in 2021, nearly 24,530 malignant brain tumors cases will be diagnosed in the USA and around 18,600 people are expected to die from the same. Brain tumor have a survival rate is just 5 year. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for brain tumor drugs market over the forthcoming years.

Brain Tumor Drugs Market Restraints

The key restraints on the brain tumor drugs market include:

High Costs of Drugs

High costs associated with anti-cancer drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. The drug from NextSource Biotechnology is used to treat glioblastoma and other brain tumors and can cost as much as $1,000 a capsule. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of brain tumor drug manufacturers.

Brain Tumor Drugs Market Trends

Major trends influencing the brain tumor drugs market include:

Combination Of Drugs To Help With Treatment

Companies operating in the brain tumor drugs market are increasingly adopting the use of a combination of drugs to treat a brain tumor. In 2021, a combination of two medicines is being tested as a therapy for glioblastoma, an aggressive kind of brain cancer. These medicines work by allowing the immune system to focus on the tumor. Two patients in a phase 1 clinical study have shown encouraging outcomes.  For example, trials conducted by UCSF Benioff Children’s Hospitals in 2018 show personalized drug cocktails to treat aggressive brain tumors in children offers new strategies in the treatment for high-grade glioma and increases chances of survival.

Adapting Phase Zero Clinical Trials

Companies operating in the brain tumor drugs market are focusing on clinical trials of new drugs. Drug discovery and medicinal chemistry are in an era of productivity and innovation. The rush of new experimental drugs for brain tumors faces obstacles that can be avoided with a more efficient system such as the phase 0 clinical trial. Phase 0 trials are generally conducted amongst fewer patients and uses small doses of a new drug to help identify which new therapies warrant accelerated development and, which new therapies are destined for failure by asking the questions in human modes rather than the usual animal mode.  For example, in ABT-888 phase 0 trial which was oncology’s first phase 0 trial, peripheral blood mononuclear cells (PBMCs) were used as surrogate tissue.

Opportunities And Recommendations In The Brain Tumor Drugs Market

Opportunities –The top opportunities in the brain tumor drugs market segmented by drugs will arise in the others segment, which will gain $2,494.7 million of global annual sales by 2025. The top opportunities in the brain tumor drugs market segmented by end-user will arise in hospital pharmacies segment, which will gain $1,804.9 million of global annual sales by 2025.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the brain tumor companies to focus on combination of drugs to help with treatment, adopt phase zero clinical trials, focus on nanotechnology for drug delivery and tumor treatment, focus on expansion of cell and gene therapy & CAR-T for brain tumors, expanding in emerging markets, set up authorized distributors and sales representatives, bundled payments, skimmed pricing, adopt premium pricing, participate in trade shows and events, increase visibility through business websites and listing websites, use big data analytics to improve marketing activities, targeting hospitals and pharmacies to spread awareness, and targeting the geriatric population.

Brain Tumor Drugs Market Segmentation

The brain tumor drugs market is segmented by drugs and by end-user.
By Drugs -
The brain tumor drugs market is segmented by drugs into:
    • a) Temozolomide
    • b) Bevacizumab
    • c) Others
The others was the largest segment of the brain tumor drugs market segmented by drugs, accounting for 69.3% of the total in 2020. Going forward, the Temozolomide segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by drugs, at a CAGR of 15.2% during 2020-2025.
By End User -
The brain tumor drugs market is segmented by end user into:
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Other End-Users
The hospital pharmacies market was the largest segment of the brain tumor drugs market segmented by end-user, accounting for 53.4% of the total in 2020. Going forward, the other end-users segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by end-user, at a CAGR of 11.1% during 2020-2025.
By Geography – The brain tumor drugs market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
Asia Pacific was the largest region in the brain tumor drugs market, accounting for 31.8% of the total in 2020. It was followed by the North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the brain tumor drugs market will be Asia Pacific and Western Europe where growth will be at CAGRs of 11.8% and 9.9% respectively during 2020-2025. These will be followed by South America and North America, where the markets are expected to register CAGRs of 9.4% and 9.1% respectively during 2020-2025.

Brain Tumor Drugs Competitive Landscape

Major Competitors are:

  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Amgen Inc.
  • Pfizer Inc.
  • Merck & Co. Inc.

    • Other Competitors Include:

  • CordenPharma
  • Eisai Co., Ltd.
  • Emcure Pharmaceuticals Limited
  • AstraZeneca
  • Y-mAbs Therapeutics
  • Roche India
  • Novartis Oncology
  • Arlak Biotech
  • Healthkind labs Pvt. Ltd.
  • SwisscheM Healthcare Pvt.Ltd
  • Apikos Pharma
  • Kolaz biotech.
  • CStone Pharma
  • CARsgen Therapeutics
  • JW Therapeutics
  • BeiGene
  • Takeda Pharmaceuticals
  • Astellas Pharma Inc
  • Otsuka Pharmaceutical Co., Ltd
  • Daiichi Pharmaceutical and Sankyo
  • AQVIDA GmbH
  • Baxter International Inc
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG
  • Veropharm
  • Biocad
  • Roche
  • Bristol-Myers Squibb
  • Celon Pharma
  • Celgene Corporation
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Merck
  • Pfizer
  • Amgen
  • AstraZeneca
  • Bayer AG
  • Novartis AG
  • Sandoz AG (A Novartis Division)
  • Eurofarma Laboratórios S.A.
  • GlaxoSmithKline plc
  • TUTEUR Argentina
  • The Takeda Pharmaceutical Company Limited
  • Pierre Fabre Group
  • Celnova Pharma
  • Pfizer S.R.L.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • BIOPHARMA-MEA
  • NeoTX
  • AID Genomics Limited
  • Novartis AG
  • GlaxoSmithKline plc
  • Pfizer
  • Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
  • Julphar
  • Sanofi
  • Bayer
  • Kitov Pharma Limited
  • CureTech Ltd.
  • Neopharma
  • Eurolab
  • Aspen
  • Adcock Ingram

      • Table Of Contents

      1. Brain Tumor Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      7. Brain Tumor Drugs Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Drugs

      7.2.1. Temozolomide

      7.2.2. Bevacizumab

      7.2.3. Others

      7.3. Market Segmentation By End-User

      7.3.1. Hospital Pharmacies

      7.3.2. Retail Pharmacies/Drug Stores

      7.3.3. Other Pharmacies

      8. Brain Tumor Drugs Market Trends And Strategies

      8.1. Combination Of Drugs To Help With Treatment

      8.2. Adapting Phase Zero Clinical Trials

      8.3. Nanotechnology For Drug Delivery And Tumor Treatment

      8.4. Expansion Of Cell And Gene Therapy & CAR-T For Brain Tumors

      8.5. Increasing Mergers And Acquisitions

      9. Impact Of COVID-19 On Brain Tumor Drugs Market

      9.1. Clinical Trial Delays

      9.2. Low Usage Of Drugs

      9.3. Supply Chain Issues

      9.4. Shortage In Resources

      9.5. Impact on Patients

      9.6. Future Outlook

      10. Global Brain Tumor Drugs Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Brain Tumor Drugs Market Segmentation

      11.1. Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. Brain Tumor Drugs Market, Regional And Country Analysis

      12.1. Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Brain Tumor Drugs Market

      13.1. Asia-Pacific Brain Tumor Drugs Market Overview

      13.1.1. Region Information

      13.1.2. Impact Of COVID-19

      13.1.3. Market Information

      13.1.4. Background Information

      13.1.5. New Drug Approvals

      13.1.6. Government Initiatives

      13.1.7. Regulations

      13.1.8. Regulatory Bodies

      13.1.9. Major Associations

      13.1.10. Taxes Levied

      13.1.11. Corporate Tax Structure

      13.1.12. Investment

      13.1.13. Major Companies

      13.2. Asia-Pacific Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Brain Tumor Drugs Market: Country Analysis

      13.7. China Brain Tumor Drugs Market

      13.8. China Brain Tumor Drugs Market Overview

      13.8.1. Country Information

      13.8.2. Impact Of COVID-19

      13.8.3. Market Information

      13.8.4. Background Information

      13.8.5. New Drug Approvals

      13.8.6. Government Initiatives

      13.8.7. Regulations

      13.8.8. Regulatory Bodies

      13.8.9. Major Associations

      13.8.10. Taxes Levied

      13.8.11. Corporate Tax Structure

      13.8.12. Investment

      13.8.13. Major Companies

      13.9. China Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Brain Tumor Drugs Market

      13.14. India Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.16. India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Brain Tumor Drugs Market

      13.19. Japan Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.21. Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Brain Tumor Drugs Market

      13.24. Australia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.26. Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Brain Tumor Drugs Market

      13.29. Indonesia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.31. Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Brain Tumor Drugs Market

      13.34. South Korea Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.36. South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Brain Tumor Drugs Market

      14.1. Western Europe Brain Tumor Drugs Market Overview

      14.1.1. Region Information

      14.1.2. Impact Of COVID-19

      14.1.3. Market Information

      14.1.4. Background Information

      14.1.5. New Drug Approvals

      14.1.6. Government Initiatives

      14.1.7. Regulations

      14.1.8. Regulatory Bodies

      14.1.9. Major Associations

      14.1.10. Taxes Levied

      14.1.11. Corporate Tax Structure

      14.1.12. Investment

      14.1.13. Major Companies

      14.2. Western Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Brain Tumor Drugs Market: Country Analysis

      14.7. UK Brain Tumor Drugs Market

      14.8. UK Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.10. UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Brain Tumor Drugs Market

      14.13. Germany Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.15. Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Brain Tumor Drugs Market

      14.18. France Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.20. France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Brain Tumor Drugs Market

      15.1. Eastern Europe Brain Tumor Drugs Market Overview

      15.1.1. Region Information

      15.1.2. Impact Of COVID-19

      15.1.3. Market Information

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Brain Tumor Drugs Market: Country Analysis

      15.7. Russia Brain Tumor Drugs Market

      15.8. Russia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Brain Tumor Drugs Market

      16.1. North America Brain Tumor Drugs Market Overview

      16.1.1. Region Information

      16.1.2. Impact Of COVID-19

      16.1.3. Market Information

      16.1.4. Background Information

      16.1.5. New Drug Approvals

      16.1.6. Government Initiatives

      16.1.7. Regulations

      16.1.8. Regulatory Bodies

      16.1.9. Major Associations

      16.1.10. Taxes Levied

      16.1.11. Corporate Tax Structure

      16.1.12. Investments

      16.1.13. Major Companies

      16.2. North America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Brain Tumor Drugs Market: Country Analysis

      16.7. USA Brain Tumor Drugs Market

      16.8. USA Brain Tumor Drugs Market Overview

      16.8.1. Country Information

      16.8.2. Impact Of COVID-19

      16.8.3. Market Information

      16.8.4. Background Information

      16.8.5. New Drug Approvals

      16.8.6. Government Initiatives

      16.8.7. Regulations

      16.8.8. Regulatory Bodies

      16.8.9. Major Associations

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Brain Tumor Drugs Market

      17.1. South America Brain Tumor Drugs Market Overview

      17.1.1. Region Information

      17.1.2. Impact Of COVID-19

      17.1.3. Market Information

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Brain Tumor Drugs Market: Country Analysis

      17.7. Brazil Brain Tumor Drugs Market

      17.8. Brazil Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Brain Tumor Drugs Market

      18.1. Middle East Brain Tumor Drugs Market Overview

      18.1.1. Region Information

      18.1.2. Impact Of COVID-19

      18.1.3. Market Information

      18.1.4. Background Information

      18.1.5. New Drug Approvals

      18.1.6. Government Initiatives

      18.1.7. Regulations

      18.1.8. Regulatory Bodies

      18.1.9. Major Associations

      18.1.10. Taxes Levied

      18.1.11. Corporate Tax Structure

      18.1.12. Investments

      18.1.13. Major Companies

      18.2. Middle East Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Brain Tumor Drugs Market

      19.1. Africa Brain Tumor Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Impact Of COVID-19

      19.1.3. Market Information

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes Levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Africa Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Brain Tumor Drugs Global Market Competitive Landscape

      20.1. Company Profiles

      20.2. F. Hoffmann-La Roche Ltd

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Novartis AG

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Amgen Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Pfizer Inc.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Merck & Co., Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Brain Tumor Drugs Pipeline Analysis

      22. Key Mergers And Acquisitions In The Brain Tumor Drugs Market

      22.1. Pfizer To Acquire Trillium Therapeutics INC.

      22.2. Chimerix Acquired Oncoceutics

      22.3. Century Therapeutics Acquired Empirica Therapeutics

      22.4. Kintara Therapeutics Merged With Adgero Biopharmaceuticals

      22.5. CNS Pharmaceuticals Acquired Houston Pharmaceuticals

      22.6. TRIGR Therapeutics Collaborated With ABL Bio

      23. Global Brain Tumor Drugs Market Opportunities And Strategies

      23.1. Global Brain Tumor Drugs Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Brain Tumor Drugs Market In 2025 – Segments Offering Most New Opportunities

      23.3. Global Brain Tumor Drugs Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
    • Table 12: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 13: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 14: Asia-Pacific Brain Tumor Drugs Market , Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 15: Asia-Pacific, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 16: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 17: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 18: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 19: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 22: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 23: China Vaccine Market, COVID-19 Vaccines Approvals
    • Table 24: China, Population By Age Group, 2015-2025, Thousands
    • Table 25: China Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 26: China, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 27: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 28: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 29: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 30: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 31: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 32: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 35: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 36: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 37: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 38: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 41: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 45: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 46: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 47: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 48: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 49: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 50: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 51: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 52: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 53: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 54: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 58: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 59: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 60: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 62: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
    • Table 65: Western Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 66: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 67: Western Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 68: Western Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 69: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 70: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 71: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 72: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 73: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 74: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 77: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 78: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 79: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 80: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 83: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 84: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 85: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 86: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 89: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 90: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 91: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 92: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
    • Table 95: Eastern Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 96: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 97: Eastern Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 98: Eastern Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 99: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 100: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 101: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 107: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 108: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 109: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 110: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112: North America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 113: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 114: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 115: North America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 116: North America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 117: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 118: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 119: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 120: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 121: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 122: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 123: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 124: USA Vaccine Market, COVID-19 Vaccines Approvals
    • Table 125: USA, Population By Age Group, 2015-2025, Thousands
    • Table 126: USA Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 127: USA Home, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 128: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 129: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 130: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 131: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 134: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 135: South America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 136: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 137: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 138: South America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 139: South America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 140: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 141: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 142: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 143: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 144: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 145: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 146: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 147: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 148: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 149: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 150: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 151: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 152: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 153: Middle East Vaccine Market, COVID-19 Vaccines Approvals
    • Table 154: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 155: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 156: Middle East Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 157: Middle East Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 158: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 159: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 160: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 161: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 162: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 163: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 164: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 165: Africa Vaccine Market, COVID-19 Vaccines Approvals
    • Table 166: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 167: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 168: Africa Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 169: Africa Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
    • Table 170: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 171: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 172: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 173: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 174: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 175: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 176: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 177: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 178: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
    • Table 179: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 180:  Amgen Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Table 181: Pfizer Inc. – Financial Overview, 2016 - 2020, $ Billion
    • Table 182: Merck & Co., Inc. – Financial Performance, 2016 - 2020, $ Billion
    • Table 183: Global Brain Tumor Drugs Market, Pipeline Analysis
    • Table 184: Global Brain Tumor Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 185: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By Drugs, 2020 – 2025
    • Table 186: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By End-User, 2020 – 2025
    • Table 187: Brain Tumor Drugs- Market Data Sources

    List Of Figures

      Figure 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 4: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 5: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 6: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 8: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 9: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 12: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 16: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 20: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 32: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 36: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 40: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 48: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 60: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 64: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 68: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 72: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 84: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
    • Figure 85: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 86: Amgen Inc.  – Financial Performance, 2016 – 2020, $ Billion
    • Figure 87: Pfizer Inc.  – Financial Overview, 2016 – 2020, $ Billion
    • Figure 88: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
    Read More
    Global Gene Therapy Market 2022 – Market Opportunities And Strategies
    Read More
    The Microbiome Market Share, Market Size, And Growth Rate 2022
    Read More
    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
    Read More
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    Read More
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Read More
    Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
    View Report